
Staying One Step Ahead of Resistance
How bacteria develop resistance to antisense antibiotics - and how future therapies can be designed to reduce the risk of resistance
Long-time companion passes away at the age of 73

Prof. Dr. med. Michael P. Manns passed away on Friday, 15 August 2025, due to cancer. The former president of Hannover Medical School (MHH) was a long-standing member of the TWINCORE Supervisory Board and contributed significantly to the positive development of the research centre through his strategic vision. ‘With Michael Manns, we have lost a close confidant who understood how to best shape TWINCORE's interests from the perspective of MHH,’ said Prof. Ulrich Kalinke, Managing Director of TWINCORE. ‘We are deeply saddened by his death and express our deepest condolences to his family.’
As a renowned hepatitis expert, Michael P. Manns already had close ties to the scientific work of TWINCORE in his role as Director of the Clinic for Gastroenterology at MHH. ‘He was particularly committed to promoting young scientists, inspiring many young colleagues to pursue research and supporting their development at our joint institutions,’ says Prof. Thomas Pietschmann, Director of the Institute for Experimental Virology at TWINCORE. Pietschmann collaborated successfully with Manns on numerous research projects on the hepatitis C virus. ‘He has had a lasting impact on our field and set the next generation of infection researchers on the path to success.’

How bacteria develop resistance to antisense antibiotics - and how future therapies can be designed to reduce the risk of resistance

A team of researchers from Hamburg, Berlin, Göttingen and Hannover has provided evidence of possible cross-protection offered by an already authorised Zaire Ebola virus vaccine.

Memory B cells play a key role in adapting to new coronavirus variants